Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Tan

Showing results (291-300 of 317) with videos related to

Pageof 32
Sort By:
Nature Communications|March 28, 2020
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaLi Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, et al.
Cancer Research|September 6, 2014
Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokersVidhya G Krishnan, Philip J Ebert, Jason C Ting, et al.
The Journal of Molecular Diagnostics : JMD|March 13, 2016
Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal CancerSophie R Wang, Simeen Malik, Iain B Tan, et al.
Therapeutic Advances in Medical Oncology|April 18, 2022
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesJingshan Ho, Valerie Heong, Wei Peng Yong, et al.
Nature Aging|April 28, 2023
Detecting visually significant cataract using retinal photograph-based deep learningYih-Chung Tham, Jocelyn Hui Lin Goh, Ayesha Anees, et al.
Journal for Immunotherapy of Cancer|February 26, 2022
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignanciesPatrick Schöffski, Daniel S W Tan, Miguel Martín, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Nature Communications|January 17, 2018
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingRahul Nahar, Weiwei Zhai, Tong Zhang, et al.
Oral Oncology|October 22, 2020
Pairing a prognostic target with potential therapeutic strategy for head and neck cancerSze Min Lek, Ke Li, Qiu Xuan Tan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2020
High-Dimensional Characterization of the Systemic Immune Landscape Informs on Synergism Between Radiation Therapy and Immune Checkpoint BlockadeKevin L M Chua, Michael Fehlings, Eugenia L L Yeo, et al.
Pageof 32

Showing results (291-300 of 317) with videos related to

Sort By:
Pageof 32
Nature Communications|March 28, 2020
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaLi Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, et al.
Cancer Research|September 6, 2014
Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokersVidhya G Krishnan, Philip J Ebert, Jason C Ting, et al.
The Journal of Molecular Diagnostics : JMD|March 13, 2016
Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal CancerSophie R Wang, Simeen Malik, Iain B Tan, et al.
Therapeutic Advances in Medical Oncology|April 18, 2022
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesJingshan Ho, Valerie Heong, Wei Peng Yong, et al.
Nature Aging|April 28, 2023
Detecting visually significant cataract using retinal photograph-based deep learningYih-Chung Tham, Jocelyn Hui Lin Goh, Ayesha Anees, et al.
Journal for Immunotherapy of Cancer|February 26, 2022
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignanciesPatrick Schöffski, Daniel S W Tan, Miguel Martín, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Nature Communications|January 17, 2018
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingRahul Nahar, Weiwei Zhai, Tong Zhang, et al.
Oral Oncology|October 22, 2020
Pairing a prognostic target with potential therapeutic strategy for head and neck cancerSze Min Lek, Ke Li, Qiu Xuan Tan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2020
High-Dimensional Characterization of the Systemic Immune Landscape Informs on Synergism Between Radiation Therapy and Immune Checkpoint BlockadeKevin L M Chua, Michael Fehlings, Eugenia L L Yeo, et al.
Pageof 32